Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutation Cholangiocarcinoma

Condition:   Cholangiocarcinoma Intervention:   Drug: GNS561 + Trametinib Sponsor:   Genfit Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials